Anderson-Fabry Disease
Author:
Hauser Anna-Christine
Publisher
Springer Vienna
Reference75 articles.
1. Altarescu G, Moore DF, Schiffmann R (2005) Effect of genetic modifiers on cerebral lesions in Fabry disease. Neurology 64: 2148–2150.
2. Amann-Vesti BR, Gitzelmann G, Widmer U, Bosshard NU, Steinmann B, Koppensteiner R (2003) Severe lymphatic microangiopathy in Fabry disease. Lymphat Res Biol (3): 185–189.
3. Anderson W (1898) A case of angiokeratoma. Br J Dermat I: 113–117.
4. Banikazemi M, Ullman T, Desnick RJ (2005) Gastrointestinal manifestations of Fabry disease: Clinical response to enzyme replacement therapy. Mol Genet Metab 85(4): 255–259.
5. Beck M, Ricci R, Widmer U, Dehout F, de Lorenzo AG, Kampmann C, Linhart A, Sunder-Plassmann G, Houge G, Ramaswami U, Gal A, Mehta A (2004) Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest 34(12): 838–844.